Elevate your local knowledge
Sign up for the iNFOnews newsletter today!
Patient trial of proposed MS treatment announced, headed by BC researcher
Original Publication Date: September 28, 2012 3:36AM
Publication Updated: January 9, 2025 4:42AM
TORONTO – The federal government is going ahead with a patient trial of a controversial experimental treatment for multiple sclerosis.
Health Minister Leona Aglukkaq said Friday that researchers will begin recruiting patients on Nov. 1 to study the treatment for chronic cerebrospinal venous insufficiency, or CCSVI.
That treatment involves unblocking neck veins that Italian vascular surgeon Paolo Zamboni has suggested could be a cause of MS.
About 100 patients are expected to take part in the trial to be conducted in British Columbia and Quebec.
Vancouver MS researcher Dr. Anthony Traboulsee will head the $6-million study being funded by Ottawa, the MS Society of Canada and the provinces where the trial will take place.
Traboulsee said researchers will monitor MS patients over a two-year period in order to obtain scientific evidence on the safety and efficacy of the CCSVI procedure.
News from © The Canadian Press, . All rights reserved.
This material may not be published, broadcast, rewritten or redistributed.
Join the Conversation!
Want to share your thoughts, add context, or connect with others in your community?
You must be logged in to post a comment.
